Prognostic Impact of PD-1 and Tim-3 Expression in Tumor Tissue in Stage I-III Colorectal Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic Impact of PD-1 and Tim-3 Expression in Tumor Tissue in Stage I-III Colorectal Cancer
Authors
Keywords
-
Journal
Biomed Research International
Volume 2020, Issue -, Pages 1-13
Publisher
Hindawi Limited
Online
2020-05-15
DOI
10.1155/2020/5294043
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PD-1/PD-L1 blockade rescue exhausted CD8+ T cells in gastrointestinal stromal tumours via the PI3K/Akt/mTOR signalling pathway
- (2019) Rui Zhao et al. CELL PROLIFERATION
- Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma
- (2019) Xingming Zhang et al. BMC CANCER
- TIM-3 dictates functional orientation of the immune infiltrate in ovarian cancer
- (2019) Jitka Fucikova et al. CLINICAL CANCER RESEARCH
- Prognostic and clinicopathological value of PD-L1 in colorectal cancer: a systematic review and meta-analysis
- (2019) Lianzhou Yang et al. OncoTargets and Therapy
- Cell Counts, rather than Proportion, of CD8/PD-1 Tumor-Infiltrating Lymphocytes in a Tumor Microenvironment Associated with Pathological Characteristics of Chinese Invasive Ductal Breast Cancer
- (2019) Qingkun Song et al. Journal of Immunology Research
- Differential expression of individual transcript variants of PD-1 and PD-L2 genes on Th-1/Th-2 status is guaranteed for prognosis prediction in PCNSL
- (2019) Yasuo Takashima et al. Scientific Reports
- Morphological lymphocytic reaction, patient prognosis and PD‐1 expression after surgical resection for oesophageal cancer
- (2019) Y. Baba et al. BRITISH JOURNAL OF SURGERY
- Upregulation of PD‐1 follows tumour development in the AOM/DSS model of inflammation‐induced colorectal cancer in mice
- (2019) Mohammad Yassin et al. IMMUNOLOGY
- Immune overdrive signature in colorectal tumor subset predicts poor clinical outcome
- (2019) Marwan Fakih et al. JOURNAL OF CLINICAL INVESTIGATION
- Immune suppression and reversal of the suppressive tumor microenvironment
- (2018) Kanako Shimizu et al. INTERNATIONAL IMMUNOLOGY
- Deregulated Mucosal Immune Surveillance through Gut-Associated Regulatory T Cells and PD-1+T Cells in Human Colorectal Cancer
- (2018) Hanae Fujimoto et al. JOURNAL OF IMMUNOLOGY
- Transition of the programmed death 1 pathway from the primary colorectal cancer to its corresponding pulmonary metastasis
- (2018) Ei Miyamoto et al. JOURNAL OF SURGICAL ONCOLOGY
- Tumor cell-intrinsic Tim-3 promotes liver cancer via NF-κB/IL-6/STAT3 axis
- (2018) Hualin Zhang et al. ONCOGENE
- Downregulated Tim‑3 expression is responsible for the incidence and development of colorectal cancer
- (2018) Ping Zhang et al. Oncology Letters
- Expression of programmed cell death protein 1 (PD-1) and its ligand PD-L1 in colorectal cancer: Relationship with sidedness and prognosis
- (2018) Jonna Berntsson et al. OncoImmunology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer
- (2018) Neda Yaghoubi et al. BIOMEDICINE & PHARMACOTHERAPY
- Co-expression of TIM-3 and CEACAM1 promotes T cell exhaustion in colorectal cancer patients
- (2017) Yang Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
- (2017) Vikram R. Juneja et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The emerging role of epigenetic modifiers in repair of DNA damage associated with chronic inflammatory diseases
- (2017) Ning Ding et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- PD1-positive tumor-infiltrating lymphocytes are associated with poor clinical outcome after pulmonary metastasectomy for colorectal cancer
- (2017) Dagmar Kollmann et al. OncoImmunology
- Deubiquitination and Stabilization of PD-L1 by CSN5
- (2016) Seung-Oe Lim et al. CANCER CELL
- Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinoma
- (2016) Lik Hang Lee et al. MODERN PATHOLOGY
- Tim-3 is upregulated in human colorectal carcinoma and associated with tumor progression
- (2016) Muming Yu et al. Molecular Medicine Reports
- TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway
- (2016) Baoen Shan et al. ONCOLOGY REPORTS
- The role of lymphangiogenesis and angiogenesis in tumor metastasis
- (2016) Roman Paduch CELLULAR ONCOLOGY
- Prognostic Significance of Programmed Cell Death 1 (PD-1) or PD-1 Ligand 1 (PD-L1) Expression in Epithelial-Originated Cancer
- (2015) Yaxiong Zhang et al. MEDICINE
- Immunoscore® as a predictor of response to chemotherapy in stage II and stage III colon cancer
- (2015) Bernhard Mlecnik et al. Journal for ImmunoTherapy of Cancer
- Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma
- (2015) Danielle M Lussier et al. Journal for ImmunoTherapy of Cancer
- PD-1 and Tim-3 Regulate the Expansion of Tumor Antigen-Specific CD8+ T Cells Induced by Melanoma Vaccines
- (2013) J. Fourcade et al. CANCER RESEARCH
- Molecular mechanisms and imaging of lymphatic metastasis
- (2013) Steven T. Proulx et al. EXPERIMENTAL CELL RESEARCH
- PD-1-Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck Cancer
- (2012) C. Badoual et al. CANCER RESEARCH
- Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma
- (2012) Hang Li et al. HEPATOLOGY
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extended Co-Expression of Inhibitory Receptors by Human CD8 T-Cells Depending on Differentiation, Antigen-Specificity and Anatomical Localization
- (2012) Lukas Baitsch et al. PLoS One
- Emerging Tim-3 functions in antimicrobial and tumor immunity
- (2011) Kaori Sakuishi et al. TRENDS IN IMMUNOLOGY
- Risk Factors for Postoperative Recurrence in Patients with Pathologically T1 Colorectal Cancer
- (2011) Shuji Iida et al. WORLD JOURNAL OF SURGERY
- Programmed death-1 upregulation is correlated with dysfunction of tumor-infiltrating CD8+ T lymphocytes in human non-small cell lung cancer
- (2010) Yan Zhang et al. Cellular & Molecular Immunology
- Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion
- (2010) Xiaoyuan Huang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+T cell dysfunction in melanoma patients
- (2010) Julien Fourcade et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer
- (2009) Martin Loos et al. BMC CANCER
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation